Only a marginal part of the global population will convert to a plant-based diet, but what is more likely is that meat will be replaced with seafood. This means that seafood will become the most demanded source of protein in the future.
The global seafood market size was valued at USD 338.47 billion in 2022 and is poised to grow to USD 730.28 billion by 2030, growing at a CAGR of 8.92% in the forecast period (2023-2030).
The increasing demand for seafood is putting a strain on wild fish stocks. It is important to find sustainable ways to produce seafood to meet the growing demand.
Most agricultural sidestreams are currently managed through incineration (40%) or landfilling (30%).
The environmental impact of agricultural sidestreams is a growing concern. The incineration and landfilling of these sidestreams can release harmful pollutants into the air and water, and they can also contribute to climate change.
In addition, the production of fishmeal and fish oil can be harmful to the environment and people whose livelihood comes from small scale fishing. In addition, the production of fishmeal can lead to the destruction of mangrove forests.
Soybean meal is another common ingredient in aquafeed. Soybean meal is a good source of protein, but it is also a major driver of deforestation. In order to produce soybean meal, large areas of forests are cleared, which releases greenhouse gases into the atmosphere and destroys habitat for wildlife.
This will reduce the environmental impact of aquaculture. Mycoprotein is a sustainable
alternative to fishmeal and fish oil because it is
produced from renewable resources.
The fungi that are used to produce mycoprotein can be grown on a variety of substrates, including agricultural sidestreams. This means that mycoprotein will be produced without putting a strain on global fish stocks or the environment.
In addition thanks to mycelium immuno-stimulating properties we could decrease the usage of antibiotics.
KIDEMIS's mycoprotein aquafeed is a sustainable, high-quality, cost-effective, and scalable alternative to fishmeal and fish oil.
It has the potential to revolutionize the aquaculture industry and help to ensure a sustainable future for food production.
Sustainable: mycoprotein is produced from renewable resources, making it a sustainable alternative to existing aquafeed.
High-quality: mycoprotein is a high-quality protein with a lot of productivity and health benefits.
Cost-effective: The cost of KIDEMIS aquafeed is disrupting the industry and making seafood more affordable to final consumers.
Scalable: KIDEMIS's mycoprotein production process is scalable, which means we can produce large quantities of mycoprotein as demand increases.
The company's mycoprotein aquafeed is produced from renewable resources and is a high-quality, cost-effective, and scalable alternative to traditional aquafeed.
KIDEMIS is proud of its Swiss roots and is committed to using Swiss technology and expertise to develop sustainable solutions for the aquaculture industry.
The country is home to many innovative companies, such as KIDEMIS, that are developing solutions to some of the world's most pressing problems. Switzerland's commitment to innovation is helping to make the world a better place.
The country is known for its high-quality products and services. Switzerland's reputation for quality is based on a number of factors, including its strong commitment to innovation, its highly skilled workforce, and its strict quality standards.
a country with a strong economy and a commitment to democracy and peace, a country has a strong economy, a stable political system, and a highly skilled workforce. Switzerland's reputation for stability and reliability makes it an ideal place to do business.
Fill out the form and we will
contact you shortly
if you want to know more about our product leave your details and we will contact you
If you would like to become a partner or sponsor fill out the form and we will contact you shortly
Thank you for your request.
We will be in touch shortly.
Former JP Morgan Chase and World Economic Forum. As the CEO of KIDEMIS, Dr. Constantin Marakhov brings extensive experience in leading and managing innovative ventures.
With a strong entrepreneurial mindset and a deep understanding of entrepreneurial activity, Dr. Marakhov provides strategic direction, oversees operations, and ensures effective project management.
Dr. Marakhov hold PhD in finance from Kyiv T. Shevchenko University and MBA from the University of Oregon.
Sean plays a pivotal role in the R&D activities of KIDEMIS.
With a background in biotechnology and a passion for sustainable solutions, Sean Wassermann spearheads the research efforts, exploring novel approaches, optimizing fermentation processes, and driving innovation in the field of solid-state fermentation.
John is former P&G executive with 30+ years tenure.
With his financial acumen he helps to ensure the project's financial stability and sustainability.
His expertise in financial analysis and risk management contributes to the overall success of the project. He also has a great network that will be critical as Kidemis will need to hire further talents and also raise further financing.
Michel Ollier (Top 10 Biotech Woman of the Year 2013) is a co-founder and Venture Partner at Medicxi.
Prior to Medicxi, Michèle was a Partner at Index Ventures for 10 years, having joined in 2006. Michèle currently serves on the board of a number of portfolio companies as well as on the board of Ipsen pharmaceuticals and the investment committee of the transfer technology accelerator SATT Paris Saclay.
She has a long and successful track record in early stage investments in Biotech. Michèle will help the team to best position and talk to future investors during the growth-phase of the company. She also has a great network.
Knut Haanaes is Professor of Strategy and Lundin Chair Professor of Sustainability.
His research and teaching focus on strategy, sustainability, strategic renewal, and business models.
He joined IMD in 2016 from BCG, where he was a senior partner and Global Leader of Strategy Practice. He also led BCG’s collaboration with MIT on sustainability, developing one of the largest databases globally of how executives address the topic, and founded the BCG Global Sustainability Initiative.
Prof. Haanaes was Dean of the Global Leadership Institute at the World Economic Forum between 2018 and 2020.